, Volume 57, Issue 7, pp 755–756 | Cite as

Guillain Barré syndrome-related posterior reversible encephalopathy syndrome

  • Giulio ZuccoliEmail author
  • Raffaele Nardone
  • Abdel-Hamid Hoda
Letter to the Editor

Dear Sir,

Reversible posterior encephalopathy syndrome (PRES), first described by Hinchey et al. in 1996, is a neurological condition characterized by headache, nausea/vomiting, seizures, visual field disturbances, altered sensorium, decreased alertness, and focal neurological deficits. The main finding of PRES on magnetic resonance imaging (MRI) is usually bilateral, often symmetric, posterior white matter hyperintensity on T2 weighted images, consistent with vasogenic edema [1]. PRES can develop in association with a variety of conditions that may cause acute alteration of blood pressure such as preeclampsia/eclampsia, as well exposure to chemotherapeutic drugs. Concurrent occurrence of Guillain-Barré syndrome (GBS) with PRES is a rare entity and only a few cases have been reported. GBS is considered a post-infectious syndrome triggered by different organisms or illnesses. The pathophysiology of the disease is most likely due to molecular mimicry.

We report the unique case of PRES in...


Pediatric Intensive Care Unit White Matter Hyperintensity Posterior Reversible Encephalopathy Syndrome Vasogenic Edema IVIG Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Ethical standards and patient consent

We declare that all human and animal studies have been approved by the University of Pittsburgh Medical Center Institutional Review Board and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. We declare that the patient’s representative gave informed consent prior to inclusion in this study.

Conflict of interest

We declare that we have no conflict of interest.


  1. 1.
    Lamy C, Oppenheim C, Méder JF, Mas JL (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging Off J Am Soc Neuroimaging 14:89–96CrossRefGoogle Scholar
  2. 2.
    Servillo G, Striano P, Striano S et al (2003) Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med 29:2323–2326. doi: 10.1007/s00134-003-1901-1 PubMedCrossRefGoogle Scholar
  3. 3.
    Rigamonti A, Basso F, Scaccabarozzi C, Lauria G (2012) Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome: case report and review of the literature. J Peripher Nerv Syst JPNS 17:356–360. doi: 10.1111/j.1529-8027.2012.00416.x CrossRefGoogle Scholar
  4. 4.
    Mathy I, Gille M, Van Raemdonck F et al (1998) Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 98:347–351PubMedGoogle Scholar
  5. 5.
    Incecik F, Hergüner MO, Altunbasak S, Yıldızdas D (2011) Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barré syndrome. J Pediatr Neurosci 6:138–140. doi: 10.4103/1817-1745.92841 PubMedCentralPubMedGoogle Scholar
  6. 6.
    Banakar BF, Pujar GS, Bhargava A, Khichar S (2014) Guillain-Barre syndrome with posterior reversible encephalopathy syndrome. J Neurosci Rural Pract 5:63–65. doi: 10.4103/0976-3147.127877 PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Etxeberria A, Lonneville S, Rutgers M-P, Gille M (2012) Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome. Rev Neurol (Paris) 168:283–286. doi: 10.1016/j.neurol.2011.06.006 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Giulio Zuccoli
    • 1
    Email author
  • Raffaele Nardone
    • 2
  • Abdel-Hamid Hoda
    • 3
  1. 1.Section of NeuroradiologyChildren’s Hospital of Pittsburgh of the University of Pittsburgh Medical CenterPittsburghUSA
  2. 2.Department of Neurology, Christian Doppler KlinikParacelsus Medical UniversitySalzburgAustria
  3. 3.Department of Child NeurologyChildren Hospital of Pittsburgh of the University of Pittsburgh Medical CenterPittsburghUSA

Personalised recommendations